Anemia in new-onset congestive heart failure inpatients admitted for acute decompensation

被引:19
作者
Formiga, Francesc
Chivite, David
Castaner, Olga
Manito, Nicolas
Maria Ramon, Josep
Pujol, Ramon
机构
[1] Hosp Univ Bellvitge, Dept Internal Med, Internal Med Serv, Geriatr Unit, Barcelona 08907, Spain
[2] Hosp Univ Bellvitge, Serv Cardiol, Barcelona, Spain
[3] Hosp Univ Bellvitge, Prevent Med & Epidemiol Serv, Barcelona, Spain
关键词
heart failure; anemia; mortality;
D O I
10.1016/j.ejim.2005.11.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Anemia may have important deleterious effects on patients with heart failure. We investigated the presence and causes of anemia among patients admitted because of new-onset congestive heart failure. The prognostic value of anemia was also evaluated. Methods: We evaluated the presence of anemia, which was defined as hemoglobin concentrations lower than 13 g/dl in men and lower than 12 g/dl in women. One-year mortality and hospital readmission rates were also studied. Results: A total of 103 patients were included in the study. Their mean age was 78.5 years and 53% were women. Mean hemoglobin levels were 12.4 g/l. Forty-four patients (43%) had anemia at the time of hospital admission, 34 of them had true anemia and 10 spurious anemia caused by hemodilution. Patients taking preadmission angiotensin-converting enzyme inhibitors had more severe anemia than those not taking them (p < 0.01). The presence of anemia was not associated with an increase in mortality (p = 0.3) or in readmission rates (p = 0.1) after 1 year of follow-up. Conclusions: Anemia is frequent in new-onset heart failure patients admitted for acute decompensation. However, the presence of anemia does not seem to be related to an increase in mortality or readmission in this small cohort. (C) 2006 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 30 条
[1]   Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction [J].
Al-Ahmad, A ;
Rand, WM ;
Manjunath, G ;
Konstam, MA ;
Salem, DN ;
Levey, AS ;
Sarnak, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) :955-962
[2]  
ANAND IS, 1993, BRIT HEART J, V70, P357
[3]   Hemodilution is common in patients with advanced heart failure [J].
Androne, AS ;
Katz, SD ;
Lund, L ;
LaManca, J ;
Hudaihed, A ;
Hryniewicz, K ;
Mancini, DM .
CIRCULATION, 2003, 107 (02) :226-229
[4]  
[Anonymous], [No title captured]
[5]  
CHARLSON ME, 1987, J CHRON DIS, V40, P378
[6]   Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT1 antagonists [J].
Chatterjee, B ;
Nydegger, UE ;
Mohacsi, P .
EUROPEAN JOURNAL OF HEART FAILURE, 2000, 2 (04) :393-398
[7]   Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes? [J].
Cromie, N ;
Lee, C ;
Struthers, AD .
HEART, 2002, 87 (04) :377-378
[8]  
Crosato Martino, 2003, Heart Fail Monit, V4, P2
[9]   HEMODYNAMIC RESPONSE TO CHRONIC ANEMIA [J].
DUKE, M ;
ABELMANN, WH .
CIRCULATION, 1969, 39 (04) :503-&
[10]   Anemia is common in heart failure and is associated with poor outcomes - Insights from a cohort of 12,065 patients with new-onset heart failure [J].
Ezekowitz, JA ;
McAlister, FA ;
Armstrong, PW .
CIRCULATION, 2003, 107 (02) :223-225